Alnylam joins Illumina and NashBio’s Alliance for Genomic Discovery to expand its 250,000 genome dataset and fuel RNAi research.
TipRanks on MSN
Oxford Nanopore Expands Share Capital with New Equity Issue
Oxford Nanopore Technologies PLC ( ($GB:ONT) ) has issued an announcement. Oxford Nanopore Technologies PLC has announced the issuance of 630,273 ...
RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring, pharmacogenetic mapping, and ...
At ASTRO, Artera presented clinical validation data on its prostate cancer test in an Asian population,and showed how the test may complement gene expression-based approaches.
Simplifying single-cell analysis for faster biomedical discoveriesAnalyzing single-cell RNA sequencing (scRNA-seq) data is ...
18hon MSN
AI tool detects hidden warning signs of disease by analyzing genetic building blocks within cells
McGill University researchers have developed an artificial intelligence tool that can detect previously invisible disease ...
A revolutionary RNA mapping method could let us learn from history’s greatest thinkers—starting with Einstein himself.
22hon MSN
Software tool helps scientists interpret complex spatial data across healthy and diseased tissue
Researchers at the Icahn School of Medicine at Mount Sinai in New York, Boston Medical Center, and Boston University ...
Researchers at the Icahn School of Medicine at Mount Sinai in New York, Boston Medical Center, and Boston University ...
Recent studies led by an international consortium of researchers, including scientists from the San Diego Zoo Wildlife ...
Discover Daiichi Sankyo's Q2 2024 earnings, updated revenue forecasts, oncology pipeline advances, and global partnerships.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback